Cell No. : Cell Name
RCB0775 : F-36P
update : 2022/11/16
|
| Comment | GM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin. |
| Comment from the depositor | |
| Terms and conditions | No restriction, but the user needs depositor's approval to use for any commercial purpose. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Chiba, Shigeru
|
| Originator |
Chiba, Shigeru
|
| Year of deposit |
1992
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
Japanese
|
| Gender |
Male
|
| Age at sampling |
65 years
|
| Tissue |
bone marrow
|
| Disease name |
myelodysplastic syndrome
|
| Classification |
cancer
|
| Year of origin |
1989
|
|
Lifespan |
infinite
|
| Morphology |
lymphocyte-like
|
| Cellosaurus(Expasy) |
CVCL_2037
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
| Culture medium |
|
RPMI1640 + 5% FBS + 5ng/ml human IL-3
|
| Antibiotics |
|
Free
|
|
Passage method |
|
dilution
|
Culture information
|
Passage ratio |
|
1 : 2-8 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma |
|
(-)
|
| Virus (HIV) |
|
(-)
|
| Virus (HTLV-1) |
|
(-)
|
| Isozyme |
|
LD, NP
|
| Chromosome mode |
|
39-122(50) : /40(1),41(4),42(8),43(17),44(17),85(1)/
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
2
|
| User's Publication |
7
|
| Reference |
|
4815
Honda H, Shibuya M, Chiba S, Yazaki Y, Hirai H.
Identification of novel protein-tyrosine phosphatases in a human leukemia cell line, F-36P.
Leukemia
1993
7(5):742-6
PubMed ID: 8483328
|
|
1673
Chiba S, Takaku F, Tange T, Shibuya K, Misawa C, Sasaki K, Miyagawa K, Yazaki Y, Hirai H
Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.
Blood
1991
78:2261-8
PubMed ID: 1834251
|
| User's Publication |
|
14629
Asayama T, Tamura H, Ishibashi M, Kuribayashi-Hamada Y, Onodera-Kondo A, Okuyama N, Yamada A, Shimizu M, Moriya K, Takahashi H, Inokuchi K.
Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes
Oncotarget
2017
8(51):88904-88917
PubMed ID: 29179486
DOI: 10.18632/oncotarget.21492
|
|
14398
Shintani T, Ohara-Waki F, Kitanaka A, Tanaka T, Kubota Y.
Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase
Blood Cells Mol Dis
2014
53(4):211-8
PubMed ID: 25084697
DOI: 10.1016/j.bcmd.2014.06.005
|
|
17142
Hu XM, Yuan B, Tanaka S, Song MM, Onda K, Tohyama K, Zhou AX, Toyoda H, Hirano T.
Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines
Hematology
2014
19(6):352-60
PubMed ID: 24192507
DOI: 10.1179/1607845413Y.0000000138
|
|
15792
Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y, Yoshida K, Okuno Y, Bando M, Nakato R, Ishikawa S, Sato-Otsubo A, Nagae G, Nishimoto A, Haferlach C, Nowak D, Sato Y, Alpermann T, Nagasaki M, Shimamura T, Tanaka H, Chiba K, Yamamoto R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Nakamaki T, Ishiyama K, Nolte F, Hofmann WK, Miyawaki S, Chiba S, Mori H, Nakauchi H, Koeffler HP, Aburatani H, Haferlach T, Shirahige K, Miyano S, Ogawa S.
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
Nat Genet
2013
45(10):1232-7
PubMed ID: 23955599
DOI: 10.1038/ng.2731
|
|
8517
Fukumoto T, Kubota Y, Kitanaka A, Yamaoka G, Ohara-Waki F, Imataki O, Ohnishi H, Ishida T, Tanaka T.
Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
Cell. Signal.
2009
21:1775-83
PubMed ID: 19665053
DOI: 10.1016/j.cellsig.2009.07.013
|
|
17308
Kobayashi N, Saeki K, Yuo A.
Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce cell cycle progression through the synthesis of c-Myc protein by internal ribosome entry site-mediated translation via phosphatidylinositol 3-kinase pathway in human factor-dependent leukemic cells
Blood
2003
102(9):3186-95
PubMed ID: 12855588
DOI: 10.1182/blood-2003-02-0567
|
|
4877
Miyoshi S, Motohashi T, Nakamura Y, Osawa M, Hiroyama T, Kim DK, Tokumoto Y, Nakauchi H.
A transmembrane trap method for efficient cloning of genes encoding proteins possessing transmembrane domain.
Biochem Biophys Res Commun
2001
289(5):1192-8
PubMed ID: 11741319
DOI: 10.1006/bbrc.2001.6097
|
Back
Top
CELL BANK Website
